Showing 8,581 - 8,600 results of 103,595 for search '(( 50 ((ppm decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.64s Refine Results
  1. 8581
  2. 8582
  3. 8583
  4. 8584
  5. 8585
  6. 8586
  7. 8587

    Gene expression. by Bo Huang (30906)

    Published 2018
    Subjects:
  8. 8588
  9. 8589

    Bone resorption. by Bo Huang (30906)

    Published 2018
    Subjects:
  10. 8590
  11. 8591

    Cell migration assay. by Bo Huang (30906)

    Published 2018
    Subjects:
  12. 8592

    Cell proliferation. by Bo Huang (30906)

    Published 2018
    Subjects:
  13. 8593

    ROS levels. by Bo Huang (30906)

    Published 2018
    Subjects:
  14. 8594

    Cell apoptosis assay. by Bo Huang (30906)

    Published 2018
    Subjects:
  15. 8595

    Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals ov... by Salma, Younes

    Published 2023
    “…We measured the levels of neutralizing total antibodies (NtAbs), anti-S-RBD IgG, and anti-S1 IgA titers among VN and NI up to ∼10 months from administration of the first dose, and up to ∼7 months from SARS-CoV-2 infection, respectively. …”
    Get full text
    Get full text
    Get full text
  16. 8596

    Mapping Pathological Phenotypes in a Mouse Model of CDKL5 Disorder by Elena Amendola (565348)

    Published 2014
    “…Here we describe the physiological, molecular, and behavioral phenotyping of a <i>Cdkl5</i> conditional knockout mouse model of CDKL5 disorder. …”
  17. 8597
  18. 8598
  19. 8599
  20. 8600

    Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals ov... by Salma, Younes

    Published 2023
    “…We measured the levels of neutralizing total antibodies (NtAbs), anti-S-RBD IgG, and anti-S1 IgA titers among VN and NI up to ∼10 months from administration of the first dose, and up to ∼7 months from SARS-CoV-2 infection, respectively. …”
    Get full text
    Get full text
    Get full text
    article